Petros Pharmaceuticals (PTPI) News Today → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free PTPI Stock Alerts $0.64 -0.04 (-5.84%) (As of 04:28 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePetros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Healthfinance.yahoo.com - April 25 at 1:37 PMPetros Pharmaceuticals, Inc.: Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA Through New Agreement with Lemonaid Healthfinanznachrichten.de - April 23 at 11:32 AMPositive Outlook for Petros Pharmaceuticals: Buy Rating Affirmed Amidst FDA Advances and Promising Stendra Developmentsmarkets.businessinsider.com - April 18 at 8:38 AMPetros Pharma Stock Down, Despite Positive Results For Stendra Studymarkets.businessinsider.com - April 2 at 11:16 AMPTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023investorplace.com - April 2 at 10:04 AMPetros Pharmaceuticals, Inc.: Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Providerfinanznachrichten.de - March 20 at 6:51 AMPetros Pharmaceuticals Inc Ordinary Shares PTPImorningstar.com - March 6 at 6:19 PMPetros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Providerfinance.yahoo.com - February 14 at 1:06 PMmarketbeat.com - February 14 at 9:36 AMPetros Pharmaceuticals Inc (PTPI)uk.investing.com - January 30 at 10:31 AMPetros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switchfinance.yahoo.com - January 24 at 2:25 PMPetros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switchfinance.yahoo.com - January 17 at 10:12 AMBuy Rating on Petros Pharmaceuticals Amid Positive User Experience and Strategic FDA Pathway Compliancemarkets.businessinsider.com - December 14 at 12:30 PMPetros Pharma Stock (NASDAQ:PTPI) Insider Tradesbenzinga.com - December 12 at 12:26 PMPetros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Providerfinance.yahoo.com - December 12 at 12:26 PMPetros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Statusfinance.yahoo.com - December 12 at 12:26 PMMaxim Group Initiates Coverage of Petros Pharmaceuticals (PTPI) with Buy Recommendationnasdaq.com - December 9 at 8:52 PMPetros Pharma Stock (NASDAQ:PTPI), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 9 at 10:34 AMPetros Pharmaceuticals initiated with bullish view at Maximrealmoney.thestreet.com - December 8 at 10:33 PMPetros Pharmaceuticals Inc Ordinary Sharesmorningstar.com - December 7 at 7:46 PMPetros Pharmaceuticals, Inc.: Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor's OTC Switch Technology Providerfinanznachrichten.de - December 5 at 10:07 AMPetros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor's (rosuvastatin) OTC Switch Technology Providerfinance.yahoo.com - December 5 at 10:07 AMPetros Pharmaceuticals Petros Pharmaceuticals Developing Artificial Intelligence Technology for Phase 2 Equivalent Study for STENDRA(R)finance.yahoo.com - October 30 at 3:35 PMFollowing Encouraging FDA Feedback Petros Pharmaceuticals Initiates Self-Selection (Phase 2-Equivalent) Study for STENDRAfinance.yahoo.com - October 19 at 12:19 PMPetros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Labelfinanznachrichten.de - October 4 at 3:40 PMPetros Pharmaceuticals Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Labelfinance.yahoo.com - October 4 at 10:39 AMPetros Pharmaceuticals to Present at the LD Micro Main Event XVIfinance.yahoo.com - September 28 at 1:03 PMPetros Pharmaceuticals, Inc.: Petros Pharmaceuticals Provides Letter to Shareholdersfinanznachrichten.de - September 11 at 7:23 PMPetros Pharmaceuticals Provides Letter to Shareholdersfinance.yahoo.com - September 11 at 7:23 PMPetros Pharmaceuticals, Inc.: Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinanznachrichten.de - September 6 at 9:16 PMPetros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 4:16 PMPetros Pharmaceuticals Down 9% After Capital Raise Newsmarketwatch.com - July 14 at 2:54 PMPetros Pharmaceuticals Announces $15M Private Placementbenzinga.com - July 13 at 10:25 PMPetros Pharmaceuticals Announces Capital Raise of $15 Millionfinance.yahoo.com - July 13 at 5:24 PMmarketbeat.com - July 12 at 11:41 AMmarketbeat.com - July 12 at 11:18 AMmarketbeat.com - April 21 at 9:58 AMmarketbeat.com - April 20 at 10:11 AMmarketbeat.com - April 20 at 9:58 AMmarketbeat.com - April 18 at 9:36 AMmarketbeat.com - April 17 at 10:21 AMmarketbeat.com - April 17 at 9:36 AMUS Equity Futures Mixed Ahead of Retail Sales, Industrial Production, Consumer Sentiment Reportsmsn.com - April 14 at 5:25 PMWhy Is Petros Pharmaceuticals (PTPI) Stock Up 101% Today?investorplace.com - April 14 at 9:18 AMmarketbeat.com - March 6 at 9:38 AMPetros Pharmaceuticals, Inc.: Petros Pharmaceuticals Announces Reverse Stock Splitfinanznachrichten.de - November 30 at 2:51 PMPetros Pharmaceuticals Announces Reverse Stock Splitfinance.yahoo.com - November 30 at 2:51 PMPetros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Updatefinance.yahoo.com - November 15 at 9:45 AMNew FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomyfinance.yahoo.com - October 25 at 10:59 AMPetros Pharmaceuticals to Participate in Two October 2022 Conferencesfinance.yahoo.com - October 21 at 3:20 PM Get Petros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar... Get your free information kit NOW, before it's too late. PTPI Media Mentions By Week PTPI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTPI News Sentiment▼0.000.37▲Average Medical News Sentiment PTPI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTPI Articles This Week▼00▲PTPI Articles Average Week Get Petros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: China Pharma News Today Lipella Pharmaceuticals News Today Exicure News Today Artelo Biosciences News Today NexImmune News Today Bright Minds Biosciences News Today Oragenics News Today Cingulate News Today Ensysce Biosciences News Today Genprex News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PTPI) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
